Home > Boards > US Listed > Biotechs >

Jounce Therapeutics Inc. (JNCE)

JNCE RSS Feed
Add JNCE Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/30/2019 9:10:47 PM - Followers: 2 - Board type: Free - Posts Today: 0

Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. The Company is engaged in developing therapies that enable the immune system to attack tumors. Through the use of its Translational Science Platform, the Company first focuses on specific cell types within tumors to prioritize targets, and then identify related biomarkers designed to match the right therapy to the right patient. The Company’s lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator (ICOS), a protein on the surface of certain T cells found in a range of solid tumors. The Company has initiated JTX-2011 multi-arm Phase I/II clinical trial in patients with solid tumors. The Company is also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. The Company is developing JTX-4014, a fully human Immunoglobulin G 4 (IgG4) monoclonal antibody.
JNCE
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
JNCE News: Jounce Therapeutics to Present Two Posters from the JTX-4014 and Vopratelimab Programs at the Society for Immunotherapy of Ca... 10/01/2019 06:01:00 PM
JNCE News: Jounce Therapeutics Names Jacquelyn Fahey Sandell as Chief Legal Officer and Corporate Secretary 09/17/2019 08:00:00 AM
JNCE News: Current Report Filing (8-k) 09/04/2019 08:52:48 AM
JNCE News: Jounce Therapeutics to Present at Upcoming Investor Conferences in September 08/28/2019 08:00:00 AM
JNCE News: Quarterly Report (10-q) 08/07/2019 11:25:18 AM
PostSubject
#4   JNCE - Huge Buyers Hit Market At Different TopMarketGainers 07/30/19 09:10:47 PM
#3   NICE NEWS!!!! UP OVER $1.00 AFTER HOURS!! now invest 07/23/19 11:30:45 PM
#2   Partner Fund Management, L.P. has filed a new wiltonio 09/30/17 02:24:52 AM
#1   JNCE bullish 24.61 stocktrademan 05/11/17 01:49:16 PM
PostSubject